Radiofrequency Ablation and Thyroid Nodules: Updated Systematic Review

Overview

Journal Endocrine

Specialty Endocrinology

Date 2021 Jan 15

PMID 33449296

Citations 19

Authors

Haris Muhammad

Prasanna Santhanam

Jonathon O Russell

Affiliations

Soon will be listed here.

Abstract

Purpose: In the thyroid gland, radiofrequency ablation (RFA) is being applied to both benign nodules and cancers internationally, while interest is also growing in the West. Benign thyroid nodules (BTNs) may be candidates for intervention when symptoms develop. For differentiated thyroid cancers (DTC), surgery is currently the first-line treatment. However, for candidates with high surgical risk or those who refuse to undergo repeated surgery, newer techniques such as RFA are an option. Surgery is associated with complications including hypothyroidism, voice change, hypocalcemia, and a scar. RFA has been used in Asian and European institutions as an alternative to surgery, but is relatively new in North America. Although RFA is not associated with significant complications, few randomized control trials have assessed its efficacy. The studies to date suggest a low rate of severe complications and a small need for thyroid hormone replacement following RFA. Further large-scale studies focusing on a Western population are needed. The aim of this review is to evaluate the evidence with respect to the current studies and data about the safety and efficacy of radiofrequency ablation for the management of BTNs and DTC.

Methods: We systematically searched the PubMed/MEDLINE, EMBASE, Clinical Queries, and Web of Science databases, for articles published up to April 30th, 2020.

Results: Total of 75 studies that met the inclusion criteria were included in the review. Thirty-five studies focused on RFA use for solid nodules, 12 studies on predominantly cystic nodules, 10 for autonomously functioning thyroid nodules, and 18 studied were published on differentiated thyroid cancer.

Conclusions: RFA seems to be an effective and safe alternative to surgery in high-risk surgical patients with thyroid cancers and for selected BTNs. Additional trials with longer follow-up in North American patients are needed to validate its full role in the armamentarium of thyroid ologists.

Citing Articles

Recurrent laryngeal nerve thermal injury in radiofrequency ablation for papillary thyroid carcinoma and related risk factors: a prospective large cohort study.

Hua Q, Song Y, Zhou W, Liu Z, Zhang L, Zhu Y Eur Radiol. 2025; .

PMID: 40050454 DOI: 10.1007/s00330-025-11448-w.

Radio Frequency Ablation of Enlarged Thyroid Nodules: A Case Report.

Muminiy S, Harhash T, Soni A, Yunatanov A, Mordukhay M, Mavash N Cureus. 2024; 16(11):e73200.

PMID: 39650960 PMC: 11624618. DOI: 10.7759/cureus.73200.

Thyroid Screening Techniques via Bioelectromagnetic Sensing: Imaging Models and Analytical and Computational Methods.

Varvari A, Pitilakis A, Karatzidis D, Kantartzis N Sensors (Basel). 2024; 24(18).

PMID: 39338849 PMC: 11435840. DOI: 10.3390/s24186104.

Efficacy of microwave ablation in the treatment of large benign thyroid nodules: a multi-center study.

Cang Y, Fan F, Liu Y, Li J, Pang C, Xu D Eur Radiol. 2024; 34(10):6852-6861.

PMID: 38546792 DOI: 10.1007/s00330-024-10614-w.

Radiofrequency ablation of thyroid nodules: a clinical review of treatment complications.

Issa P, Cironi K, Rezvani L, Kandil E Gland Surg. 2024; 13(1):77-86.

PMID: 38323235 PMC: 10839694. DOI: 10.21037/gs-22-539.

References

Guang Y, He W, Luo Y, Zhang H, Zhang Y, Ning B . Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up. BMC Cancer. 2019; 19(1):147. PMC: 6375217. DOI: 10.1186/s12885-019-5338-5. View

Hegedus L . Thyroid ultrasonography as a screening tool for thyroid disease. Thyroid. 2005; 14(11):879-80. DOI: 10.1089/thy.2004.14.879. View

Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K . Papillary microcarcinoma of the thyroid: how should it be treated?. World J Surg. 2004; 28(11):1115-21. DOI: 10.1007/s00268-004-7644-5. View

Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K . An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003; 13(4):381-7. DOI: 10.1089/105072503321669875. View

Su S, Grodski S, Serpell J . Hypothyroidism following hemithyroidectomy: a retrospective review. Ann Surg. 2009; 250(6):991-4. DOI: 10.1097/SLA.0b013e3181ae5426. View

Chen S, Zaborek N, Doubleday A, Schaefer S, Long K, Pitt S . Optimizing Levothyroxine Dose Adjustment After Thyroidectomy With a Decision Tree. J Surg Res. 2019; 244:102-106. PMC: 7041547. DOI: 10.1016/j.jss.2019.06.025. View

Alexander E, Hurwitz S, Heering J, Benson C, Frates M, Doubilet P . Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003; 138(4):315-8. DOI: 10.7326/0003-4819-138-4-200302180-00010. View

Bergenfelz A, Jansson S, Kristoffersson A, Martensson H, Reihner E, Wallin G . Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg. 2008; 393(5):667-73. DOI: 10.1007/s00423-008-0366-7. View

10.

Hegedus L . Therapy: a new nonsurgical therapy option for benign thyroid nodules?. Nat Rev Endocrinol. 2009; 5(9):476-8. DOI: 10.1038/nrendo.2009.152. View

11.

Rhim H, Goldberg S, Dodd 3rd G, Solbiati L, Lim H, Tonolini M . Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001; 21 Spec No:S17-35; discussion S36-9. DOI: 10.1148/radiographics.21.suppl_1.g01oc11s17. View

12.

Buscarini , Rossi . Technology for Radiofrequency Thermal Ablation of Liver Tumors. Semin Laparosc Surg. 1997; 4(2):96-101. DOI: 10.1053/SLAS00400096. View

13.

Barile A, Quarchioni S, Bruno F, Ierardi A, Arrigoni F, Giordano A . Interventional radiology of the thyroid gland: critical review and state of the art. Gland Surg. 2018; 7(2):132-146. PMC: 5938274. DOI: 10.21037/gs.2017.11.17. View

14.

Lee J, Shin J, Hahn S, Park K, Choi J . Feasibility of Adjustable Electrodes for Radiofrequency Ablation of Benign Thyroid Nodules. Korean J Radiol. 2020; 21(3):377-383. PMC: 7039717. DOI: 10.3348/kjr.2019.0724. View

15.

Kim J, Baek J, Lim H, Ahn H, Baek S, Choi Y . 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018; 19(4):632-655. PMC: 6005940. DOI: 10.3348/kjr.2018.19.4.632. View

16.

Gharib H, Hegedus L, Pacella C, Baek J, Papini E . Clinical review: Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013; 98(10):3949-57. DOI: 10.1210/jc.2013-1806. View

17.

Papini E, Pacella C, Hegedus L . Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedures: from the shadows into an array of applications. Eur J Endocrinol. 2014; 170(4):R133-46. DOI: 10.1530/EJE-13-0917. View

18.

Che Y, Jin S, Shi C, Wang L, Zhang X, Li Y . Treatment of Benign Thyroid Nodules: Comparison of Surgery with Radiofrequency Ablation. AJNR Am J Neuroradiol. 2015; 36(7):1321-5. PMC: 7965284. DOI: 10.3174/ajnr.A4276. View

19.

Huh J, Baek J, Choi H, Kim J, Lee J . Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session--prospective randomized study. Radiology. 2012; 263(3):909-16. DOI: 10.1148/radiol.12111300. View

20.

Arora N, Scognamiglio T, Zhu B, Fahey 3rd T . Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg. 2008; 32(7):1237-46. DOI: 10.1007/s00268-008-9484-1. View

21.

Wang C, Friedman L, Kennedy G, Wang H, Kebebew E, Steward D . A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2010; 21(3):243-51. PMC: 3698689. DOI: 10.1089/thy.2010.0243. View